The IFP-regulated TGF-β signaling is also a contributing mechanism to the antigen heterogeneity in solid tumors, as it can downregulate epithelial cell adhesion cofactor (EpCAM) expression on the surface of tumor cells. The gene discussed is EPCAM; the disease is neoplasm.